# A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B

> **NCT07307586** · PHASE3 · RECRUITING · sponsor: **Zhigang Ren** · enrollment: 120 (estimated)

## Conditions studied

- Chronic Hepatitis B
- Azvudine

## Interventions

- **DRUG:** AZVUDINE
- **DRUG:** TAF
- **DRUG:** IFNα-2a

## Key facts

- **NCT ID:** NCT07307586
- **Lead sponsor:** Zhigang Ren
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07307586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07307586, "A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07307586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*